Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
PMID: 35536017
Tirzepatide was originally developed to treat type 2 diabetes, but clinical trials revealed a striking finding: non-diabetic adults experienced significant weight loss when using this medication
The STEP trials demonstrated average weight loss of 14.9% of body weight at 68 weeks with the 2.4mg weekly dose
You tend to lose track of payment schedules
So are the hormones that control growth, reproduction, and tissue repair
Because the trial is randomized and blinded, it is possible she actually received the sham procedure
US$ 20.21
US$ 28.35
US$ 29.33
